Verapamil

Contraindicated

Verapamil Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of colchicine toxicity Details Verapamil Dofetilide Tikosyn Increased dofetilide exposure, an increased risk of QT interval prolongation, and an increased risk of torsades de pointes Details

Major

Verapamil Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Verapamil Abametapir Explained Increased exposure of CYP3A4 substrate Details Verapamil Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Verapamil Relugolix Orgovyx Explained Increased relugolix exposure Details Verapamil Simvastatin Flolipid Explained Increased simvastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Verapamil Acalabrutinib Calquence Increased acalabrutinib exposure and increased risk of toxicity Details Verapamil Apixaban Eliquis Explained Increased apixaban exposure and increased risk of bleeding Details Verapamil Atenolol Tenormin Explained An increased risk of hypotension, bradycardia and slow AV conduction Details Verapamil Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Verapamil Betrixaban Bevyxxa® Increased betrixaban exposure and increased risk of bleeding Details Verapamil Acebutolol Sectral® An increased risk of hypotension, bradycardia and slow AV conduction Details Verapamil Atorvastatin Atorvaliq Increased exposure to atorvastatin and an increased risk of myopathy or rhabdomyolysis Details Verapamil Cariprazine Vraylar Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Verapamil Afatinib Gilotrif Increased exposure of afatinib Details Verapamil Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Verapamil Bedaquiline Sirturo Increased bedaquiline exposure Details Verapamil Betaxolol Betoptic S An increased risk of hypotension, bradycardia and slow AV conduction Details Verapamil Betaxolol Ophthalmic Betoptic® An increased risk of hypotension, bradycardia and slow AV conduction Details Verapamil Bisoprolol Zebeta® An increased risk of hypotension, bradycardia and slow AV conduction Details Verapamil Bosutinib Bosulif Increased bosutinib exposure Details Verapamil Brexpiprazole Rexulti Increased brexpiprazole exposure Details Verapamil Brigatinib Alunbrig Increased brigatinib exposure Details Verapamil Budesonide Entocort Increased budesonide exposure Details Verapamil Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Verapamil Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Verapamil Clonidine Transdermal Patch Catapres An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Verapamil Clopidogrel Plavix Decreased antiplatelet effect and increased risk of thrombotic events Details Verapamil Cobimetinib Cotellic Increased cobimetinib plasma concentrations Details Verapamil Cyclosporine Injection Atopica An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Verapamil Cyclosporine Ophthalmic Cequa An increased risk of cycloSPORINE toxicity (renal dysfunction, cholestasis, paresthesias) Details Verapamil Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Verapamil Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Verapamil Deflazacort Emflaza Increased exposure to active metabolite of deflazacort Details Verapamil Digoxin Cardoxin® Increased digoxin exposure, increased risk of digitalis toxicity and an increased risk of complete heart block Details Verapamil Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Verapamil Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Verapamil Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Verapamil Edoxaban Savaysa Increased edoxaban exposure Details